These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8089070)

  • 21. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients.
    Goldschmidt H; Hahn U; Salwender HJ; Haas R; Jansen B; Wolbring P; Rinck M; Hunstein W
    Zentralbl Bakteriol; 1995 Dec; 283(2):215-23. PubMed ID: 8825113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters.
    Dünser MW; Mayr AJ; Hinterberger G; Flörl CL; Ulmer H; Schmid S; Friesenecker B; Lorenz I; Hasibeder WR
    Anesth Analg; 2005 Dec; 101(6):1778-1784. PubMed ID: 16301258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.
    Ciresi DL; Albrecht RM; Volkers PA; Scholten DJ
    Am Surg; 1996 Aug; 62(8):641-6. PubMed ID: 8712561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
    Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
    J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters.
    Sampath LA; Tambe SM; Modak SM
    Infect Control Hosp Epidemiol; 2001 Oct; 22(10):640-6. PubMed ID: 11776351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
    Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
    Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture.
    Schierholz JM; Bach A; Fleck C; Beuth J; König D; Pulverer G
    J Hosp Infect; 2000 Feb; 44(2):141-5. PubMed ID: 10662565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review.
    Donelli G; Francolini I
    J Chemother; 2001 Dec; 13(6):595-606. PubMed ID: 11806619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review.
    Gilbert RE; Harden M
    Curr Opin Infect Dis; 2008 Jun; 21(3):235-45. PubMed ID: 18448967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections.
    Tennenberg S; Lieser M; McCurdy B; Boomer G; Howington E; Newman C; Wolf I
    Arch Surg; 1997 Dec; 132(12):1348-51. PubMed ID: 9403542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of antibacterial impregnated central venous catheters against Klebsiella pneumoniae.
    Yorganci K; Krepel C; Weigelt JA; Edmiston CE
    Intensive Care Med; 2002 Apr; 28(4):438-42. PubMed ID: 11967598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
    Rosato AE; Tallent SM; Edmond MB; Bearman GM
    Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial-coated/bonded and -impregnated intravascular catheters.
    Pai MP; Pendland SL; Danziger LH
    Ann Pharmacother; 2001 Oct; 35(10):1255-63. PubMed ID: 11675856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.
    Walz JM; Avelar RL; Longtine KJ; Carter KL; Mermel LA; Heard SO;
    Crit Care Med; 2010 Nov; 38(11):2095-102. PubMed ID: 20711070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious risk associated with arterial catheters compared with central venous catheters.
    Lucet JC; Bouadma L; Zahar JR; Schwebel C; Geffroy A; Pease S; Herault MC; Haouache H; Adrie C; Thuong M; Français A; Garrouste-Orgeas M; Timsit JF
    Crit Care Med; 2010 Apr; 38(4):1030-5. PubMed ID: 20154601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.
    Ballo MK; Rtimi S; Pulgarin C; Hopf N; Berthet A; Kiwi J; Moreillon P; Entenza JM; Bizzini A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5349-56. PubMed ID: 27353266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.